View:
FORM 8-A
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) or (g) OF THE
SECURITIES EXCHANGE ACT OF 1934
BioTime, Inc.
(Exact name of registrant as specified in its charter)
California
(State of incorporation or organization)
94-3127919
(I.R.S. Employer Identification No.)
935 Pardee Street, Berkeley, California 94710
(Address of Principal executive offices) (Zip Code)
Securities to be registered pursuant to Section 12(b) of the Act:
Title of each class Name of each exchange on which
to be so registered each class is to be registered
___________________ ______________________________
None
Securities to be registered pursuant to Section 12(g) of the Act:
Common Share Subscription Rights
(Title of Class)
Item 1. Description of Registrant's Securities to be Registered.
Common Share Subscription Rights
The Common Share Subscription Rights ("Rights") entitle the holders thereof
to subscribe for and purchase up to an aggregate of 283,109 common shares, no
par value ("Common Shares") of the BioTime, Inc. (the "Company"). Holders of
Rights will be entitled to subscribe for and purchase from the Company one new
Common Share for every ten Rights held (the "Primary Subscription"). The Rights
may be exercised at any time during the Subscription Period, which commences on
January 10, 1997 and ends at 5:00 p.m. New York time on February 4, 1997 (the
"Expiration Date"). The subscription price per Common Share (the "Subscription
Price") will be $20.00.
Shareholders, including beneficial owners of shares held in the name of
Cede & Co. as nominee for The Depositary Trust Company or in the name of any
other depositary or
nominee, as of the close of business on December 27, 1996 (the "Record Date")
who fully exercise their Rights will be entitled to the additional privilege
subscribing for and purchasing, subject to certain limitations and subject to
allocation, any Common Shares not acquired by other holders of Rights through
the exercise of such Rights.
Item 2. Exhibits.
1. A copy of the certificate for the security being registered is included
as Exhibit 4(e) to Amendment No. 1 to Registrant's Registration
Statement on Form S-3, No. 333- 17321, filed with the Commission on
January 10, 1997, which exhibit is incorporated herein by reference.
2. Articles of Incorporation, as amended, are included as Exhibit 3(a) to
Registrant's Registration Statement on Form S-1, No. 33-44549, filed
with the Commission on December 18, 1991, and Amendment No. 1 and
Amendment No. 2 thereto filed with the Securities and Exchange
Commission on February 6, 1992 and March 7, 1992, respectively, which
exhibit is incorporated herein by reference.
3. Bylaws, as amended, are included as Exhibit 3(c) to Registrant's
Registration Statement on Form S-1, No. 33-48717 and Post-Effective
Amendment No. 1 thereto, filed with the Securities and Exchange
Commission on June 22, 1992 and August 27, 1992, respectively, which
exhibit is incorporated herein by reference.
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities Exchange
Act of 1934, the registrant has duly caused this registration statement to be
signed on its behalf by the undersigned, thereto duly authorized.
Date: January 9, 1997 BioTime, Inc.
By: s/Paul Segall
______________________
Paul Segall, President
2